OCT 30, 2014 12:00 PM PDT

What is best practice for testing for unexpected pregnancy in pediatric and adult patients prior to cancer diagnostics, imaging and therapy?

Speaker
  • Chief, Pathology at Lucile Packard Children's Hospital at Stanford, Associate Professor in the Department of Pathology, Stanford University
    BIOGRAPHY

Abstract

Female cancer patients in the reproductive years face a variety of diagnostic and therapeutic procedures which pose teratogenic hazards to an unexpected pregnancy. Ionizing radiation, diagnostic biopsy and surgical resection procedures, anesthesia, chemotherapeutic agents and nuclear medicine scans are commonplace interventions which are contraindicated in the presence of a pregnancy, yet may be required for cancer diagnosis and treatment. Woman facing such procedures are tested for pregnancy so that decision-making regarding pregnancy and the need for cancer treatment can be made prospectively, and to avoid potential iatrogenic harm, emotional distress for the patient, and liability for the physician. There are substantial knowledge gaps amongst physicians regarding the limitations of the different tests. It is critically important that the physician understand the types of available human chorionic gonadotropin (HCG) tests; the differences in sample types (urine or serum); and the locations where the tests can be performed. Analytical sensitivities differ between urine and blood HCG tests, which yield differences of several days in pregnancy detection. Reasons for erroneous urine HCG results will be examined. Variability between measurements, test interferences and HCG variants will be discussed. The clinical impact of using the right test on the right sample at the right time on sexually active female cancer patients in their reproductive years will be highlighted.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
OCT 12, 2021 9:00 AM PDT
C.E. CREDITS
OCT 12, 2021 9:00 AM PDT
Date: October 12, 2021 Time: 9:00am (PDT), 12:00pm (EDT) SCIEX’s next-generation Biologics Explorer software is an innovative platform for the comprehensive and deep characterization o...
OCT 30, 2014 12:00 PM PDT

What is best practice for testing for unexpected pregnancy in pediatric and adult patients prior to cancer diagnostics, imaging and therapy?



Show Resources
Loading Comments...
Show Resources